EEF2K and neoplasm: In addition to several reported eEF2K-interacting proteins like eEF235 and Homer1,36 GSK3β, a key regulator of tumor immunity by inducing phosphorylation-dependent PD-L1 proteasomal degradation,11 was shown to be a potential partner of eEF2K (figure 3A).